Condition
Aneurysmal Subarachnoid Hemorrhage clinical trials and research
As of November 12, 2026, Find a Trial lists 15 Aneurysmal Subarachnoid Hemorrhage clinical trials that are recruiting, at sites in 8 countries (most in China (6), United States (5), Netherlands (1)). By phase: Phase 2 (3), Phase 1 (1), Phase 3 (1), Phase 4 (1). The most active sponsors are Beijing Tiantan Hospital (3), Second Affiliated Hospital of Nanchang University (2). There are also 6 NIH-funded research projects on Aneurysmal Subarachnoid Hemorrhage, with $1.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 15Clinical trials
- 6NIH research projects
- 8Countries
Newest Aneurysmal Subarachnoid Hemorrhage clinical trials
All recruiting trials (15)
-
Nitric Oxide Use to Predict Vasospasm in Aneurysmal Subarachnoid Hemorrhage
This study tests whether nitric oxide consumption in CSF can predict cerebral vasospasm in patients with aneurysmal SAH.
-
Multi-omics program to understand complications and outcomes after aneurysmal subarachnoid hemorrhage
This project will test if combining blood, cerebrospinal fluid, urine, imaging, and multi-omics data can find biomarkers that predict complications and outcomes in adults with aneurysmal subarachnoid hemorrhage.
-
Dome-only coiling for severe aneurysmal subarachnoid hemorrhage
This will test a minimally invasive dome-protection coiling procedure to prevent re-bleeding in adults who have had a severe aneurysmal subarachnoid hemorrhage.
-
Cilostazol to help prevent delayed brain ischemia after aneurysm bleed
This study tests whether cilostazol can reduce delayed brain ischemia and improve outcomes after aneurysmal subarachnoid hemorrhage in adults who had recent aneurysm treatment.
-
Transcutaneous Vagal Nerve Stimulation to help with brain vessel narrowing after aneurysm rupture
This trial tests whether using a noninvasive nerve stimulation device can reduce cerebral vasospasm after an aneurysmal brain bleed in adults 18–65 who are undergoing standard treatment.
-
Tocilizumab-aazg to reduce stroke risk after a ruptured brain aneurysm
This trial will try to see if a single IV dose of tocilizumab-aazg is safe and can help prevent delayed strokes in adults who have had a ruptured brain aneurysm (aneurysmal subarachnoid hemorrhage).
-
Using human albumin to improve outcomes in patients with aneurysmal subarachnoid hemorrhage
This study is testing if giving human albumin to patients with a type of brain hemorrhage can help improve their recovery compared to standard fluid treatments.
-
Collecting real-life data on endovascular treatments for brain aneurysms
This study is collecting real-life information on how safe and effective a specific type of device is for treating brain aneurysms in patients.
-
Fludrocortisone for adults with aneurysmal subarachnoid hemorrhage
This trial tests whether giving early enteral fludrocortisone to adults hospitalized with aneurysmal subarachnoid hemorrhage reduces death and long-term disability at six months.
-
Using intrathecal nicardipine to treat vasospasm after aneurysmal subarachnoid hemorrhage
This study is testing if giving nicardipine directly into the spine can help patients with vasospasm after a brain bleed feel better compared to regular treatment.
-
Combining lumbar drainage with urokinase for treating severe aneurysmal subarachnoid hemorrhage
This study is testing if a combination of spinal drainage and a special medication can help people with severe brain bleeding recover better than those who don’t receive the treatment.
-
Registry study on factors predicting outcomes in aneurysmal subarachnoid hemorrhage
This study is trying to find out what factors can help predict how well people with aneurysmal subarachnoid hemorrhage will do after their condition and improve how they are treated.
-
Long-term outcomes for patients with aneurysmal subarachnoid hemorrhage
This study looks at how well different treatments for aneurysmal subarachnoid hemorrhage work over the long term for patients who have had this condition.
-
Using Deferoxamine to treat Aneurysmal Subarachnoid Hemorrhage
This study is testing if a drug called deferoxamine can help people with aneurysmal subarachnoid hemorrhage recover better by reducing complications from iron release.
-
Using Nadroparin to Improve Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage
This study is testing if giving higher doses of Nadroparin can help patients who have had an aneurysmal subarachnoid hemorrhage live longer and have better recovery outcomes compared to standard doses.
NIH-funded research (6)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Cognitive screening after an aneurysmal brain bleed
Using patient questionnaires to find thinking and memory problems in people recovering from aneurysmal subarachnoid hemorrhage.
-
Molecularly mapping early brain injury after brain bleed using human brain organoids and patient CSF
Scientists are studying how early brain injury after aneurysmal subarachnoid hemorrhage happens in people, by using patient CSF and human brain organoids to find what signals cause damage and why women may have worse outcomes.
-
Understanding metabolic changes after brain hemorrhage
This study is looking at how a serious brain condition called aneurysmal subarachnoid hemorrhage affects the body's metabolism and inflammation, with the goal of finding ways to predict how well patients will recover by analyzing blood samples.
-
Using Satralizumab to treat complications from brain aneurysms.
This study is looking at how well the drug Satralizumab can help people recover after a brain aneurysm by reducing complications like vasospasm, and it’s designed for patients who have had this type of hemorrhage.
-
Identifying brain injury risks in patients with aneurysmal subarachnoid hemorrhage using brain activity monitoring.
This study is looking at how to better manage blood pressure for people who have had a brain bleed from an aneurysm, by closely monitoring their brain activity to find the best targets for blood flow, which could help prevent further complications and improve recovery.
-
Improving cognitive assessment after brain hemorrhages for better patient outcomes
This study is looking to improve how we spot and understand thinking problems in people who have had a brain bleed, especially focusing on African American and rural patients who might not get the help they need, so we can help them live better lives.
Related topics
Quick answers
How many Aneurysmal Subarachnoid Hemorrhage clinical trials are recruiting right now?
15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in China (6 trials), United States (5 trials), Netherlands (1 trial), Australia (1 trial), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.